Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Fiorilli

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Biomedicines|February 25, 2023
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot StudyFrancesca La Gualana, Francesca Maiorca, Ramona Marrapodi, et al.
Annals of Hematology|August 31, 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from ItalyMarcella Visentini, Andrea Pica, Giancarlo D'Ippolito, et al.
Genes and Immunity|February 19, 2020
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disordersYlenia A Minafò, Martina Del Padre, Cristina Cristofoletti, et al.
Frontiers in Immunology|February 27, 2023
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21<sup>low</sup> B cells in hepatitis C virus-cured mixed cryoglobulinemiaMartina Del Padre, Ramona Marrapodi, Ylenia A Minafò, et al.
Autoimmunity Reviews|May 17, 2011
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infectionMarcella Visentini, Serena Ludovisi, Antonio Petrarca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2019
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitisMarcella Visentini, Martina Del Padre, Stefania Colantuono, et al.
Frontiers in Immunology|February 16, 2026
Case Report: Extracorporeal photopheresis for cutaneous lupus erythematosus induces putatively atheroprotective B and T cell responsesMarcella Visentini, Maria Ozsvar-Kozma, Ilenia Pacella, et al.
Autoimmunity Reviews|June 3, 2015
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic reviewMarcella Visentini, Carmine Tinelli, Stefania Colantuono, et al.
Hepatology (Baltimore, Md.)|August 3, 2016
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemiaLaura Gragnani, Marcella Visentini, Elisa Fognani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2019
Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related MalignanciesLaura Dotta, Lucia Dora Notarangelo, Daniele Moratto, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Biomedicines|February 25, 2023
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot StudyFrancesca La Gualana, Francesca Maiorca, Ramona Marrapodi, et al.
Annals of Hematology|August 31, 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from ItalyMarcella Visentini, Andrea Pica, Giancarlo D'Ippolito, et al.
Genes and Immunity|February 19, 2020
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disordersYlenia A Minafò, Martina Del Padre, Cristina Cristofoletti, et al.
Frontiers in Immunology|February 27, 2023
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21<sup>low</sup> B cells in hepatitis C virus-cured mixed cryoglobulinemiaMartina Del Padre, Ramona Marrapodi, Ylenia A Minafò, et al.
Autoimmunity Reviews|May 17, 2011
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infectionMarcella Visentini, Serena Ludovisi, Antonio Petrarca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2019
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitisMarcella Visentini, Martina Del Padre, Stefania Colantuono, et al.
Frontiers in Immunology|February 16, 2026
Case Report: Extracorporeal photopheresis for cutaneous lupus erythematosus induces putatively atheroprotective B and T cell responsesMarcella Visentini, Maria Ozsvar-Kozma, Ilenia Pacella, et al.
Autoimmunity Reviews|June 3, 2015
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic reviewMarcella Visentini, Carmine Tinelli, Stefania Colantuono, et al.
Hepatology (Baltimore, Md.)|August 3, 2016
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemiaLaura Gragnani, Marcella Visentini, Elisa Fognani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2019
Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related MalignanciesLaura Dotta, Lucia Dora Notarangelo, Daniele Moratto, et al.
Pageof 5